Search Results 771-780 of 4522 for 搜索留痕最新技术咨询邮箱：lgooxc@hotmail.com

  1. A Study to Determine How Corneal Transparency is Affected in Fuchs Dystrophy - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Mayo Clinic SCORE on Sex Differences - Contact

    Contact the Mayo Clinic SCORE on Sex Differences about its research on hormonal changes and aging or about funding opportunities and research support.

  3. Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer - Mayo Clinic

    About this study. The objective of the program is to provide access to TAS-102 to patients with metastatic colorectal cancer who are refractory to or ...

  4. Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer, the ENHANCE Study - Mayo Clinic

    About this study. The purposes of this study are to evaluate whether pre-NAC peripheral blood immune phenotypes (defined by mass cytometry) are associated ...

  5. Transcutaneous Spinal Cord Stimulation Enabling Reflex Motor Evoked Responses with Spina Bifida - Mayo Clinic

    About this study. The purpose of this study is to characterize the motor function deficits specific to muscle weakness, intra and interlimb coordination, ...

  6. Division of Clinical Trials and Biostatistics - Focus areas

    Biomarker-stratified and biomarker enrichment designs. Cluster randomized trial designs. Collection and analysis of adverse event data in oncology trials.

  7. CYP2C19 Genotype Predictor of Gastric Acid Suppression - Mayo Clinic

    About this study. If CYP2C19 genotype can predict the efficacy of healing erosive esophagitis and gastric acid secretion in patients taking once a day ...

  8. Alumni - Brain and Systemic Aging: Marissa J. Schafer - Mayo Clinic Research

    Jair Machado Espindola Netto, Ph.D. 2023-2025; Principle Research Technologist. Merve Atik, M.D.; 2024; Student. Paul Gomez, B.S.; 2022-2024 ...

  9. Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3) - Mayo Clinic

    Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3) · Overview.

  10. A Study to Evaluate TAK-018 for Prevention of the Recurrence of Postoperative Crohn's Disease (CD) - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness of TAK-018 in reducing endoscopic recurrence of intestinal inflammation in postoperative participants ...